Article

Short-Term Psychodynamic Psychotherapy and Fluoxetine in Major Depressive Disorder: A Randomized Comparative Study

Department of Psychiatry, University of Helsinki, Helsinki, Finland.
Psychotherapy and Psychosomatics (Impact Factor: 9.2). 09/2008; 77(6):351-7. DOI: 10.1159/000151388
Source: PubMed

ABSTRACT

There are few studies comparing the efficacy of short-term psychodynamic psychotherapy (STPP) and pharmacotherapy in major depressive disorder. We conducted a comparative study on the efficacy of STPP versus fluoxetine treatment in patients with major depressive disorder in a primary care setting.
Fifty-one patients with major depressive disorder (DSM-IV) of mild or moderate severity were recruited through occupational health services providing primary health care. Patients were randomized to receive either STPP (1 session/week) or fluoxetine treatment (20-40 mg/day) for 16 weeks. The outcome measures included the Hamilton Depression Rating Scale (HDRS), the Beck Depression Inventory (BDI), and the Social and Occupational Functioning Assessment Scale (SOFAS).
Intent-to-treat analyses indicated that both treatments were highly effective in reducing the HDRS (p < 0.0001) and BDI (p < 0.0001) scores, as well as in improving functional ability (SOFAS; p < 0.0001), with no statistically significant differences between the treatments. Of those 40 subjects who completed the follow-up, 57% in the psychotherapy group and 68% in the fluoxetine group showed full remission (HDRS <or=7) after 4 months.
Both STPP and pharmacological treatment with fluoxetine are effective in reducing symptoms and in improving functional ability of primary care patients with mild or moderate depression. This study suggests no marked differences in the therapeutic effects of these two treatment forms in a primary care setting.

Download full-text

Full-text

Available from: Juha Antero Markkula
  • Source
    • "These results are consistent with the findings of the meta-analysis by Wampold, Minami, Baskin, and Tierney (2002) who did not find significant differences between CBT and " other therapies " in the treatment of depression. In an RCT by Salminen et al. (2008), psychodynamic psychotherapy was found to be equally efficacious as fluoxetine in reducing symptoms of depression and improving functional ability. However, with sample sizes of n 1 = 26 and n 2 = 25, statistical power may have not been sufficient to detect possible differences between treatments. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This article reviews the empirical evidence for psychodynamic therapy for specific mental disorders in adults. The focus is on randomized controlled trials (RCTs). However, this does not imply that RCTs are uncritically accepted as the gold standard for demonstrating that a treatment works. According to the results presented here, there is evidence from RCTs that psychodynamic therapy is efficacious in common mental disorders, that is, depressive disorders, anxiety disorders, somatic symptom disorders, personality disorders, eating disorders, complicated grief, posttraumatic stress disorder (PTSD), and substance-related disorder. These results clearly contradict assertions repeatedly made by representatives of other psychotherapeutic approaches claiming psychodynamic psychotherapy is not empirically supported. However, further research is needed, both on outcome and processes of psychodynamic psychotherapy. There is a need, for example, for RCTs of psychodynamic psychotherapy of PTSD. Furthermore, research on long-term psychotherapy for specific mental disorders is required.
    Full-text · Article · Apr 2014 · Contemporary psychoanalysis
  • Source
    • "gov.br/base/visadoc/BM/BM(34652-1-0).PDF). A fluoxetina foi escolhida pela sua excelente relação custo-benefício em comparação com os custos de tratamento da depressão (Salminen et al., 2008). Na primeira consulta psiquiátrica, os pacientes receberam explicações sobre o tratamento medicamentoso e receberam fluoxetina suficiente para duas semanas de tratamento, quando , então, tiveram a segunda consulta. "
    [Show abstract] [Hide abstract]
    ABSTRACT: A depressão é uma doença grave, com repercussões importantes no humor e na cognição. Tratamentos farmacológicos e/ou psicoterápicos estão comumente indicados. O presente estudo objetivou avaliar e comparar a cognição de pacientes deprimidos antes e após 12 meses de tratamento com fluoxetina ou psicoterapia psicodinâmica. Cento e oitenta pacientes foram divididos em dois grupos, e avaliados por meio da WAIS-III. Os resultados mostraram uma melhora significativa em diferentes subtestes da WAIS-III. A MANOVA indicou que há uma diferença significativa entre os grupos nas pontuações médias obtidas na reavaliação 12 meses após o início dos tratamentos. Os resultados sugerem que a psicoterapia psicodinâmica e a terapia com fluoxetina agem de forma diferente na cognição de pacientes deprimidos.
    Full-text · Article · Dec 2013 · Psicologia Teoria e Pesquisa
  • Source
    • "These recommendations start with 20 mg of fluoxetine per day during two to four weeks and, if necessary, gradual increase of dosage up to a maximum of 60 mg per day. Fluoxetine was chosen for its excellent cost-effectiveness comparing to the costs of depression treatment (Salminen et al., 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Randomized controlled trials (RCTs) examining the efficacy of different forms of therapy for depression are relatively common. However, there are not many RCTs comparing neurocognitive effects of these treatments. Neurocognitive changes across three types of treatment for depression were compared. Long-term psychodynamic psychotherapy (LTPP) was compared with fluoxetine treatment, and their combination, in the treatment of moderate depression. A 272 adult patients with beck depression inventory (BDI) scores 20-35 were randomized to receive LTPP, fluoxetine monotherapy or their combination for a 24 months period. The Wechsler adult intelligence scale version III (WAIS-III) was the primary neuropsychological measure. Multilevel mixed model analyses indicated that there were neurocognitive changes within and between treatments, with statistically significant differences over time (p>.01). LTPP and combined treatment seemed to be more efficacious in modifying specific areas of cognition than fluoxetine alone. Sample very homogenous, threatening external validity. LTPP and its combination with fluoxetine demonstrated to be effective for specific neurocognitive increasing in patients with moderate depression. This study suggests marked differences over time in the neurocognitive effects between the three treatment forms compared. Results found here may be of clinical relevance for building bridges between pharmacotherapy and psychodynamic psychotherapy.
    Full-text · Article · Sep 2013 · Journal of Affective Disorders
Show more